| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
2e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
2e-05 |
| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.0006 |